Skip to main content
Karen Melendez, MD, Psychiatry, Statesville, NC

Karen L Melendez MD

Child & Adolescent Psychiatry


Physician

Join to View Full Profile
  • 1703 Davie AveStatesville, NC 28677

  • Phone+1 704-819-9191

  • Fax+1 704-872-3782

Are you Dr. Melendez?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Karen Melendez, MD is a board certified psychiatrist in Statesville, North Carolina. She is currently licensed to practice medicine in North Carolina, South Carolina, and Pennsylvania.

Education & Training

  • University of Southern California/Los Angeles General Medical Center (USC/LA General)
    University of Southern California/Los Angeles General Medical Center (USC/LA General)Fellowship, Child and Adolescent Psychiatry, 2006 - 2008
  • Temple University Hospital
    Temple University HospitalResidency, Psychiatry, 2003 - 2006
  • Lewis Katz School of Medicine at Temple University
    Lewis Katz School of Medicine at Temple UniversityClass of 2003

Certifications & Licensure

  • CA State Medical License
    CA State Medical License Current
  • NC State Medical License
    NC State Medical License 2008 - 2026
  • SC State Medical License
    SC State Medical License 2008 - 2011
  • PA State Medical License
    PA State Medical License 2003 - 2006
  • PA State Medical License
    PA State Medical License 2003 - 2006
  • Psychiatry
    American Board of Psychiatry and Neurology Psychiatry
  • Child & Adolescent Psychiatry
    American Board of Psychiatry and Neurology Child & Adolescent Psychiatry

Press Mentions

  • Despite Dwindling Demand for COVID-19 Vaccines, Bay Area Counties Plan to ‘Double Down’ on New Strategy
    Despite Dwindling Demand for COVID-19 Vaccines, Bay Area Counties Plan to ‘Double Down’ on New StrategyMay 4th, 2021